Speaker
Medical Director, Clinical Research, Amgen Inc.
Ivana Sullivan, Medical Director, Clinical Research at Amgen Inc., spoke at 8th RAS-Targeted Drug Development Summit (Boston, United States of America, 8–10 Sept 2026) in the session “Advancing First Line Care for KRAS G12C positive & PD L1 negative NSCLC: Optimizing Targeted Therapy + Chemotherapy for a High-Unmet- Need Population”.
8–10 Sept 2026Boston, United States of America
Chief Technology Officer, Anocca AB
Professor, Georgetown University
Executive Director & Head of Enzalutamide, Medical Affairs (US), Astellas Pharma
Senior Director, Translational & Preclinical Research, Verastem, inc
Chief Scientific Officer, Elicio Therapeutics
Senior Research, Pharmacology Investigator, Incyte Corporation
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ivana Sullivan, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].